Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Melanoma

Free Subscription Articles published in Melanoma Res Retrieve available abstracts of 153 articles: HTML format Text format

Single Articles

March 2010
1. DENG WG , Kwon J, Ekmekcioglu S, Poindexter NJ, et al
   IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. TESTORI A , Rastrelli M, De Fiori E, Soteldo J, et al
   Radio-guided ultrasound lymph node localization: feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastases.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. SCHARTZ NE , Farges C, Madelaine I, Bruzzoni H, et al
   Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. LEITER U , Buettner PG, Eigentler TK, Forschner A, et al
   Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. BYERS HR , Boissel SJ, Tu C, Park HY, et al
   RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. TODOROVIC V , Sersa G, Mlakar V, Glavac D, et al
   Metastatic potential of melanoma cells is not affected by electrochemotherapy.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
7. ABOURBIH DA , Di Cesare S, Orellana ME, Antecka E, et al
   Lysyl oxidase expression and inhibition in uveal melanoma.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. POPULO H , Soares P, Rocha AS, Silva P, et al
   Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. HU DN , Yu GP, McCormick SA
   Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas.
   Melanoma Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. DE GIORGI V , Gori A, Grazzini M, Rossari S, et al
    The initiation and progression of melanoma: estrogens or estrogen receptors?
    Melanoma Res. 2010;20:64-5.
    PubMed     Text format     Related articles   
    
    
    
11. SILVERTHORN CF , Alani RM
    Glyceraldehyde-3-phosphate dehydrogenase expression is altered by hypoxia in melanoma cells and primary human melanocytes.
    Melanoma Res. 2010;20:61-3.
    PubMed     Text format     Related articles   
    
    
    January 2010
12. MOUAWAD R , Spano JP, Khayat D
    Old and new serological biomarkers in melanoma: where we are in 2009.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BAIR WB 3RD , Cabello CM, Uchida K, Bause AS, et al
    GLO1 overexpression in human malignant melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. SOTELDO J , Ratto EL, Gandini S, Trifiro G, et al
    Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. WIERZBICKA-HAINAUT E , Sassolas B, Mourey L, Guillot B, et al
    Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. TOPCU-YILMAZ P , Kiratli H, Saglam A, Soylemezoglu F, et al
    Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
17. TEIXEIRA F , Akaishi E, Mendes G, Moutinho V, et al
    Mid-humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. RONDEPIERRE F , Bouchon B, Bonnet M, Moins N, et al
    B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. YANG X , Qu J, Wang S
    Primary malignant melanoma of the esophagus.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. MALECKI JM , Bentke A, Ostrowska B, Laidler P, et al
    Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. FOOTE MC , Burmeister BH, Thomas J, Mark Smithers B, et al
    A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MORRISON BW , Doudican NA, Patel KR, Orlow SJ, et al
    Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. YOON C , Papadopoulos NE, Camacho LH, McIntyre S, et al
    The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
24. AGARWALA SS
    Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. THAMM DH , Huelsmeyer MK, Mitzey AM, Qurollo B, et al
    RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. LESIAK K , Koprowska K, Zalesna I, Nejc D, et al
    Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
27. ZOHAR S , Medioni J, Lebbe C, Avril MF, et al
    Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patients.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. FERNANDEZ LP , Milne RL, Pita G, Floristan U, et al
    Human beta-defensins (HBD1 and HBD3) and malignant melanoma susceptibility.
    Melanoma Res. 2009;19:340-1.
    PubMed     Text format     Related articles   
    
    
    
29. COLLINS CM , Morgan DS, Mosse C, Sosman J, et al
    Dacarbazine induced acute myeloid leukemia in melanoma.
    Melanoma Res. 2009;19:337-40.
    PubMed     Text format     Related articles   
    
    
    
30. GARCIA-CASADO Z , Nagore E, Fernandez-Serra A, Botella-Estrada R, et al
    A germline mutation of p14/ARF in a melanoma kindred.
    Melanoma Res. 2009;19:335-7.
    PubMed     Text format     Related articles   
    
    
    
31. CHANG JW , Hsieh JJ, Shen YC, Ho E, et al
    Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma.
    Melanoma Res. 2009;19:309-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
32. SUAREZ-GARCIA C , Perez-Gil A, Pereira-Gallardo S, Codes-Villena M, et al
    Interferon-induced cutaneous sarcoidosis in melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
33. CHEN X , James Swanson R, Kolb JF, Nuccitelli R, et al
    Histopathology of normal skin and melanomas after nanosecond pulsed electric field treatment.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. PIERRET L , Van Baren N, Bonehill A, Corthals J, et al
    Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three cases.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. PETERSSON S , Shubbar E, Enerback L, Enerback C, et al
    Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Melanoma Res. 2009;19:215-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
36. SAVOIA P , Fava P, Nardo T, Osella-Abate S, et al
    Skin metastases of malignant melanoma: a clinical and prognostic survey.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. KALIALIS LV , Drzewiecki KT, Klyver H
    Spontaneous regression of metastases from melanoma: review of the literature.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. KOOMEN ER , Joosse A, Herings RM, Casparie MK, et al
    Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. VALIAHDI SM , Heffeter P, Jakupec MA, Marculescu R, et al
    The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SOLARI N , Gipponi M, Stella M, Queirolo P, et al
    Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. VEREECKEN P , Awada A, Suciu S, Castro G, et al
    Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. MARTINS I , Sylla K, Deshayes F, Lauriol J, et al
    Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
43. NAGORE E , Montoro A, Garcia-Casado Z, Botella-Estrada R, et al
    Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. GUENOVA E , Lichte V, Hoetzenecker W, Woelbing F, et al
    Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. KIRSZBERG C , Lima LG, Da Silva de Oliveira A, Pickering W, et al
    Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. ATZENI M , Serratore F, Zaccheddu F, Buosi M, et al
    Multiple melanoma arising on a burn scar and extensive sunburn: a case report and a review of the literature.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. JUHL AL , Byers TE, Robinson WA, Morelli JG, et al
    The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. KUZBICKI L , Lange D, Chwirot BW
    Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. LEE TK , Macarthur AC, Gallagher RP, Elwood MJ, et al
    Occupational physical activity and risk of malignant melanoma: the Western Canada Melanoma Study.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. AN J , Li B, Wu L, Lu H, et al
    Primary malignant amelanotic melanoma of the female genital tract: report of two cases and review of literature.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. HOMSI J , Bedikian AY, Kim KB, Papadopoulos NE, et al
    Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. KAEHLER KC , Egberts F, Lorigan P, Hauschild A, et al
    Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. PIGOZZO J , De Rossi C, Rossi CR, Nitti D, et al
    Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion.
    Melanoma Res. 2009;19:193-4.
    PubMed     Text format     Related articles   
    
    
    
54. EISEN T , Thomas J, Miller WH Jr, Gore M, et al
    Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
    Melanoma Res. 2009;19:185-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. HOMSI J , Cubitt CL, Zhang S, Munster PN, et al
    Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.
    Melanoma Res. 2009;19:167-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. DJERF EA , Trinks C, Abdiu A, Thunell LK, et al
    ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839).
    Melanoma Res. 2009;19:156-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. TELLEZ CS , Shen L, Estecio MR, Jelinek J, et al
    CpG island methylation profiling in human melanoma cell lines.
    Melanoma Res. 2009;19:146-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. GLUD M , Gniadecki R, Drzewiecki KT
    Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre.
    Melanoma Res. 2009;19:176-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
59. JACOB AI , Romigh T, Waite KA, Eng C, et al
    Nuclear PTEN levels and G2 progression in melanoma cells.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. GLUCK I , Simon AJ, Catane R, Pfeffer R, et al
    Germline analysis of thymidine/guanidine polymorphism at position 309 of the Mdm2 promoter in malignant melanoma patients.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
61. TESTORI A , Soteldo J, Sances D, Mazzarol G, et al
    Cutaneous melanoma in the elderly.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. SOARES DE SA BC , Fugimori ML, Braga Ribeiro KD, Duprat Neto JP, et al
    Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. DREISEITL S , Binder M, Hable K, Kittler H, et al
    Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. RETSAS S , Quigley M, Pectasides D, Henry K, et al
    Adjuvant treatment with vindesine for metastatic melanoma: in response to the study of Eigentler et al. (2008).
    Melanoma Res. 2009;19:123-4.
    PubMed     Text format     Related articles   
    
    
    
65. ZATTRA E , Fortina AB, Bordignon M, Piaserico S, et al
    Immunosuppression and melanocyte proliferation.
    Melanoma Res. 2009;19:63-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
66. GHIORZO P , Pastorino L, Pizzichetta MA, Bono R, et al
    CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. SANTINAMI M , Carbone A, Crippa F, Maurichi A, et al
    Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. BRADY MS , Brown K, Patel A, Fisher C, et al
    Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. LEDEZMA E , Wittig O, Alonso J, Cardier JE, et al
    Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. LAM TK , Uren RF, Scolyer RA, Quinn MJ, et al
    False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. RIDOLFI L , Fiorentini G, Guida M, Michiara M, et al
    Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HU DN , Wakamatsu K, Ito S, McCormick SA, et al
    Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
73. PJANOVA D , Molven A, Akslen LA, Engele L, et al
    Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ZHAO ZZ , Duffy DL, Thomas SA, Martin NG, et al
    Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. CHEN N , Gong J, Chen X, Xu M, et al
    Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Melanoma Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. VEIEROD MB , Parr CL, Lund E, Hjartaker A, et al
    Response: errors in assessing risk factors for melanoma.
    Melanoma Res. 2009;19:61.
    PubMed     Text format     Related articles   
    
    
    
77. COTE TR , Sobin LH
    Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
    Melanoma Res. 2009;19:58-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. LEITER U , Marghoob AA, Lasithiotakis K, Eigentler TK, et al
    Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
    Melanoma Res. 2009;19:50-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. KIM KB , Legha SS, Gonzalez R, Anderson CM, et al
    A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
    Melanoma Res. 2009;19:42-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. BASTIAANNET E , Hoekstra-Weebers JE, Francken AB, Jager PL, et al
    Perception of burden experienced during diagnostic tests by melanoma patients with lymph node metastases.
    Melanoma Res. 2009;19:36-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. BAUMERT J , Schmidt M, Giehl KA, Volkenandt M, et al
    Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype.
    Melanoma Res. 2009;19:24-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. BECKER MR , Siegelin MD, Rompel R, Enk AH, et al
    COX-2 expression in malignant melanoma: a novel prognostic marker?
    Melanoma Res. 2009;19:8-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. CAI L , Li X, Zheng S, Wang Y, et al
    Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
    Melanoma Res. 2009;19:1-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
84. EGBERTS F , Hitschler WN, Weichenthal M, Hauschild A, et al
    Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
    Melanoma Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. HOFMANN MA , Gussmann F, Fritsche A, Biesold S, et al
    Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.
    Melanoma Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. EROL B , Ufuk U, Husamettin T, Yasin U, et al
    True hematogenous metastases of melanoma on contralateral skin graft donor site: a case report.
    Melanoma Res. 2008;18:443-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. VIGNOLI M , Scaini MC, Ghiorzo P, Sestini R, et al
    Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.
    Melanoma Res. 2008;18:431-437.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. BOLANDER A , Agnarsdottir M, Wagenius G, Stromberg S, et al
    Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
    Melanoma Res. 2008;18:412-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. BEDIKIAN AY , Papadopoulos NE, Kim KB, Vardeleon A, et al
    A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
    Melanoma Res. 2008;18:400-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. HASSEL JC , Winnemoller D, Schartl M, Wellbrock C, et al
    STAT5 contributes to antiapoptosis in melanoma.
    Melanoma Res. 2008;18:378-385.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. TRIFIRO G , Verrecchia F, Soteldo J, Zonta M, et al
    Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanoma.
    Melanoma Res. 2008;18:373-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
92. VAD NM , Yount G, Moridani MY
    Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
    Melanoma Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. ROY S , Dhingra K, Mandal S, Khurana N, et al
    Unusual presentation of metastatic amelanotic melanoma of unknown primary origin as a solitary breast lump.
    Melanoma Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. TRIOZZI PL , Aldrich W, Dombos C
    Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo.
    Melanoma Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. CHIARUGI A , Nardini P, Borgognoni L, Brandani P, et al
    Clinico-pathological characteristics of familial melanoma in a Mediterranean population.
    Melanoma Res. 2008;18:367-9.
    PubMed     Text format     Related articles   
    
    
    
96. CHAKERA AH , Hansen LB, Lock-Andersen J, Drzewiecki KT, et al
    In-transit sentinel nodes must be found: implication from a 10-year follow-up study in melanoma.
    Melanoma Res. 2008;18:359-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. EIGENTLER TK , Radny P, Hauschild A, Gutzmer R, et al
    Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
    Melanoma Res. 2008;18:353-358.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. SINGH B , Ezziddin S, Palmedo H, Reinhardt M, et al
    Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
    Melanoma Res. 2008;18:346-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. RICHMOND-SINCLAIR NM , Lee E, Cummings MC, Williamson R, et al
    Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
    Melanoma Res. 2008;18:336-345.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. GU F , Qureshi AA, Niu T, Kraft P, et al
     Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma.
     Melanoma Res. 2008;18:330-335.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. CHEN J , Peng H, Ou-Yang X, He X, et al
     Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells.
     Melanoma Res. 2008;18:322-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. HUMER J , Ferko B, Waltenberger A, Rapberger R, et al
     Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
     Melanoma Res. 2008;18:314-321.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. MIKHAYLOVA IN , Kovalevsky DA, Morozova LF, Golubeva VA, et al
     Cancer/testis genes expression in human melanoma cell lines.
     Melanoma Res. 2008;18:303-313.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. MONCRIEFF M , Scolyer R, Thompson J, Beavis A, et al
     Correct identification of a sentinel node postselective lymphadenectomy using antimony levels.
     Melanoma Res. 2008;18:365-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
105. THOMPSON JF , Hersey P, Wachter E
     Chemoablation of metastatic melanoma using intralesional Rose Bengal.
     Melanoma Res. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
106. PFAHLBERG AB , Gefeller O
     Errors in assessing risk factors for melanoma: lack of reproducibility is the minor problem.
     Melanoma Res. 2008;18:300-1.
     PubMed     Text format     Related articles   
     
     
     
107. SALEMI M , Bosco P, Cali F, Calogero AE, et al
     SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Sicilian patients with melanoma.
     Melanoma Res. 2008;18:295-299.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LEE RT , Fallarino F, Ashikari A, Gajewski TF, et al
     Melanoma presenting as circulating tumor cells associated with failed angiogenesis.
     Melanoma Res. 2008;18:289-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. KALIALIS LV , Drzewiecki KT, Mohammadi M, Mehlsen AB, et al
     Spontaneous regression of metastases from malignant melanoma: a case report.
     Melanoma Res. 2008;18:279-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. HAUSCHILD A , Trefzer U, Garbe C, Kaehler KC, et al
     Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
     Melanoma Res. 2008;18:274-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. VIHINEN P , Koskivuo I, Syrjanen K, Tervahartiala T, et al
     Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
     Melanoma Res. 2008;18:268-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. SZTRAMSKA A , Dymerska D, Chwirot BW
     Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker.
     Melanoma Res. 2008;18:259-67.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. URSO C , Saieva C, Borgognoni L, Tinacci G, et al
     Sensitivity and specificity of histological criteria in the diagnosis of conventional cutaneous melanoma.
     Melanoma Res. 2008;18:253-258.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. RUTKOWSKI P , Nowecki ZI, Kulik J, Ruka W, et al
     Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
     Melanoma Res. 2008;18:246-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. HWANG CS , Prieto VG, Diwan AH, Lizee G, et al
     Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.
     Melanoma Res. 2008;18:241-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. GUNASTI S , Mulayim MK, Fettahloglu B, Yucel A, et al
     Interrater agreement in rating of pigmented skin lesions for border irregularity.
     Melanoma Res. 2008;18:284-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
117. CATAPANO-MINOTTI G , Torracca L, Rizzo N, Corsonello A, et al
     A case of metastatic melanoma in the heart: does echocardiographic screening matter?
     Melanoma Res. 2008;18:239-40.
     PubMed     Text format     Related articles   
     
     
     
118. TUOMAALA S , Kivela T
     Sentinel lymph node biopsy guidelines for conjunctival melanoma.
     Melanoma Res. 2008;18:235.
     PubMed     Text format     Related articles   
     
     
     
119. NEJC D , Chalubinska J, Piekarski J, Pluta P, et al
     Adequacy of sentinel node procedure in patients with synchronous primary skin melanoma: report of a patient with five melanomas.
     Melanoma Res. 2008;18:235-9.
     PubMed     Text format     Related articles   
     
     
     
120. CROCETTI E , Guzzinati S, Paci E, Falcini F, et al
     The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
     Melanoma Res. 2008;18:230-234.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. PERIC B , Zgajnar J, Besic N, Hocevar M, et al
     Changing biology of cutaneous melanoma.
     Melanoma Res. 2008;18:225-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. VOELTER V , Schalenbourg A, Pampallona S, Peters S, et al
     Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
     Melanoma Res. 2008;18:220-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. MITHANI SK , Smith IM, Topalian SL, Califano JA, et al
     Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.
     Melanoma Res. 2008;18:214-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. KILIC E , Bruggenwirth HT, Meier M, Naus NC, et al
     Increased expression of p73Deltaex2 transcript in uveal melanoma with loss of chromosome 1p.
     Melanoma Res. 2008;18:208-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. VUCETIC B , Rogan SA, Hrabac P, Hudorovic N, et al
     Biological value of melanoma inhibitory activity serum concentration in patients with primary skin melanoma.
     Melanoma Res. 2008;18:201-207.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. CHANG SH , Worley LA, Onken MD, Harbour JW, et al
     Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.
     Melanoma Res. 2008;18:191-200.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. WORLEY LA , Long MD, Onken MD, Harbour JW, et al
     Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.
     Melanoma Res. 2008;18:184-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. ATAYDE VD , Jasiulionis MG, Cortez M, Yoshida N, et al
     A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells.
     Melanoma Res. 2008;18:172-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. MUCHEMWA FC , Nakatsura T, Fukushima S, Nishimura Y, et al
     Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
     Melanoma Res. 2008;18:166-171.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. MOCELLIN S , Rossi CR
     The melanoma molecular map project.
     Melanoma Res. 2008;18:163-5.
     PubMed     Text format     Related articles   
     
     
     April 2008
131. GARBE C , Hauschild A, Volkenandt M, Schadendorf D, et al
     Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
     Melanoma Res. 2008;18:152-160.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. BAEL TE , Peterson BL, Gollob JA
     Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
     Melanoma Res. 2008;18:147-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. GUILLOT B , Khamari A, Cupissol D, Delaunay M, et al
     Temozolomide associated with PEG-interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study.
     Melanoma Res. 2008;18:141-146.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. FAYE RS , Paus E, Maelandsmo GM, Berner A, et al
     S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients.
     Melanoma Res. 2008;18:134-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. DE SIMONE P , Silipo V, Buccini P, Mariani G, et al
     Vulvar melanoma: a report of 10 cases and review of the literature.
     Melanoma Res. 2008;18:127-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. RIZELL M , Mattson J, Cahlin C, Hafstrom L, et al
     Isolated hepatic perfusion for liver metastases of malignant melanoma.
     Melanoma Res. 2008;18:120-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. SCHWAGER SS , Leiter U, Buettner PG, Voit C, et al
     Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
     Melanoma Res. 2008;18:112-119.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. YANG H , Fang G, Huang X, Yu J, et al
     In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases.
     Melanoma Res. 2008;18:95-103.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. SAITO A , Saito N, Mol W, Furukawa H, et al
     Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
     Melanoma Res. 2008;18:85-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. SCHWENKERT M , Birkholz K, Schwemmlein M, Kellner C, et al
     A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
     Melanoma Res. 2008;18:73-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. MONCRIEFF M , Shannon K, Hong A, Hersey P, et al
     Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy.
     Melanoma Res. 2008;18:161-2.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. HOFBAUER GF , Baur T, Bonnet MC, Tartour E, et al
     Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
     Melanoma Res. 2008;18:104-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
143. CABIBI D , Cacciatore M, Russo L, Porcasi R, et al
     The oral melanoma: atypical immunophenotype in the metastatic area.
     Melanoma Res. 2008;18:70-2.
     PubMed     Text format     Related articles   
     
     
     
144. GARBE C , Hauschild A, Volkenandt M, Schadendorf D, et al
     Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma.
     Melanoma Res. 2008;18:61-67.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. CONSTANTINIDOU A , Hofman M, O'doherty M, Acland KM, et al
     Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
     Melanoma Res. 2008;18:56-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. RAVINDRANATH MH , Muthugounder S, Presser N
     Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.
     Melanoma Res. 2008;18:47-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. CHEVALIER J , Bonastre J, Avril MF
     The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
     Melanoma Res. 2008;18:40-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. AKSLEN LA , Puntervoll H, Bachmann IM, Straume O, et al
     Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
     Melanoma Res. 2008;18:29-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. KRETSCHMER L , Thoms KM, Peeters S, Haenssle H, et al
     Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection.
     Melanoma Res. 2008;18:16-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. VAN GILS W , Kilic E, Bruggenwirth HT, Vaarwater J, et al
     Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
     Melanoma Res. 2008;18:10-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. VEIEROD MB , Parr CL, Lund E, Hjartaker A, et al
     Reproducibility of self-reported melanoma risk factors in a large cohort study of Norwegian women.
     Melanoma Res. 2008;18:1-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. SCHAFER-HESTERBERG G , Voit C
     Ultrasound pre sentinel node dissection.
     Melanoma Res. 2008;18:68-9.
     PubMed     Text format     Related articles   
     
     
     
153. MILNE E , Simpson JA, English DR
     Appearance of melanocytic nevi on the backs of young Australian children: a 7-year longitudinal study.
     Melanoma Res. 2008;18:22-8.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: